Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Award
Stock Option (Right to Buy)
2024-01-18+120,000→ 120,000 totalExercise: $7.60Exp: 2034-01-17→ Common Stock (120,000 underlying) - Sale
Common Stock
2024-01-19$7.75/sh−6,307$48,900→ 98,698 total
Holdings
- 1,911.27(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]Includes 1,944 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2024.
- [F3]The stock option will vest with respect to 25% of the shares of common stock on January 18, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.